| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Departments of
* Experimental Dermatology and
Psychiatry, University of Freiburg, Germany; and
Department of Dermatology, University of Kiel, Germany
2Correspondence: PD Dr. Johannes Norgauer, Department of Experimental Dermatology, Hauptstraße 7, D-79104 Freiburg i. Br., Germany. E-mail: Norgauer{at}haut.ukl.uni-freiburg.de
Dendritic cells (DCs) are specialized antigen-presenting cells characterized by their ability to migrate into target sites, process antigens, and activate naive T cells. In this study, we analyzed the biological activity and intracellular signaling of adenosine by using reverse transcriptase-polymerase chain reaction assays to investigate mRNA expression of A1, A2a and A3 adenosine receptors in immature and mature human DCs. Functional experiments on adenosine stimulation showed chemotaxis, intracellular calcium transients, and actin polymerization, but no activation of adenylate cyclase in immature DCs. Experiments with receptor isotype-selective agonists and antagonists as well as pertussis toxin revealed that chemotaxis, calcium transients, and actin polymerization were mediated via Gi- or G0-protein-coupled A1 and A3 receptors. Maturation of DCs induced by lipopolysaccharide (LPS) resulted in down-regulation of A1 and A3 receptor mRNAs, although A2a receptor mRNA was still expressed. However, in LPS-differentiated DCs, adenosine and an A2a receptor agonist stimulated adenylate cyclase activity, enhanced intracellular cAMP levels, and inhibited interleukin 12 (IL-12) production. These effects could be completely prevented by pretreatment with A2 receptor antagonist. These findings strongly suggest that adenosine has important but distinct biological effects in DCs activity as a chemotaxin for immature DCs and as a modulator of IL-12 production in mature DCs. These effects can be explained by differential expression of adenosine receptor subtypes.—Panther, E., Idzko, M., Herouy, Y., Rheinen, H., Gebicke-Haerter, P. J., Mrowietz, U., Dichmann, S., Norgauer, J. Expression and function of adenosine receptors in human dendritic cells.
Key Words: DCs • calcium • chemotaxis • cytokine release
This article has been cited by other articles:
|
|
 |
|
  B. Csoka, L. Himer, Z. Selmeczy, E. S. Vizi, P. Pacher, C. Ledent, E. A. Deitch, Z. Spolarics, Z. H. Nemeth, and G. Hasko Adenosine A2A receptor activation inhibits T helper 1 and T helper 2 cell development and effector function FASEB J, October 1, 2008; 22(10): 3491 - 3499. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. V. Novitskiy, S. Ryzhov, R. Zaynagetdinov, A. E. Goldstein, Y. Huang, O. Y. Tikhomirov, M. R. Blackburn, I. Biaggioni, D. P. Carbone, I. Feoktistov, et al. Adenosine receptors in regulation of dendritic cell differentiation and function Blood, September 1, 2008; 112(5): 1822 - 1831. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Takedachi, D. Qu, Y. Ebisuno, H. Oohara, M. L. Joachims, S. T. McGee, E. Maeda, R. P. McEver, T. Tanaka, M. Miyasaka, et al. CD73-Generated Adenosine Restricts Lymphocyte Migration into Draining Lymph Nodes J. Immunol., May 1, 2008; 180(9): 6288 - 6296. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Hasko and P. Pacher A2A receptors in inflammation and injury: lessons learned from transgenic animals J. Leukoc. Biol., March 1, 2008; 83(3): 447 - 455. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. E. Zarek, C.-T. Huang, E. R. Lutz, J. Kowalski, M. R. Horton, J. Linden, C. G. Drake, and J. D. Powell A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells Blood, January 1, 2008; 111(1): 251 - 259. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. N. Clark, R. Youkey, X. Liu, L. Jia, R. Blatt, Y.-J. Day, G. W. Sullivan, J. Linden, and A. L. Tucker A1 Adenosine Receptor Activation Promotes Angiogenesis and Release of VEGF From Monocytes Circ. Res., November 26, 2007; 101(11): 1130 - 1138. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Kobie, P. R. Shah, L. Yang, J. A. Rebhahn, D. J. Fowell, and T. R. Mosmann T Regulatory and Primed Uncommitted CD4 T Cells Express CD73, Which Suppresses Effector CD4 T Cells by Converting 5'-Adenosine Monophosphate to Adenosine J. Immunol., November 15, 2006; 177(10): 6780 - 6786. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Fortin, D. Harbour, M. Fernandes, P. Borgeat, and S. Bourgoin Differential expression of adenosine receptors in human neutrophils: up-regulation by specific Th1 cytokines and lipopolysaccharide J. Leukoc. Biol., March 1, 2006; 79(3): 574 - 585. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Pacheco, J. M. Martinez-Navio, M. Lejeune, N. Climent, H. Oliva, J. M. Gatell, T. Gallart, J. Mallol, C. Lluis, and R. Franco CD26, adenosine deaminase, and adenosine receptors mediate costimulatory signals in the immunological synapse PNAS, July 5, 2005; 102(27): 9583 - 9588. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Durk, E. Panther, T. Muller, S. Sorichter, D. Ferrari, C. Pizzirani, F. Di Virgilio, D. Myrtek, J. Norgauer, and M. Idzko 5-Hydroxytryptamine modulates cytokine and chemokine production in LPS-primed human monocytes via stimulation of different 5-HTR subtypes Int. Immunol., May 1, 2005; 17(5): 599 - 606. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-J. Day, Y. Li, J. M. Rieger, S. I. Ramos, M. D. Okusa, and J. Linden A2A Adenosine Receptors on Bone Marrow-Derived Cells Protect Liver from Ischemia-Reperfusion Injury J. Immunol., April 15, 2005; 174(8): 5040 - 5046. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Gessi, K. Varani, S. Merighi, E. Cattabriga, A. Avitabile, R. Gavioli, C. Fortini, E. Leung, S. M. Lennan, and P. A. Borea Expression of A3 Adenosine Receptors in Human Lymphocytes: Up-Regulation in T Cell Activation Mol. Pharmacol., March 1, 2004; 65(3): 711 - 719. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Schnurr, T. Toy, A. Shin, G. Hartmann, S. Rothenfusser, J. Soellner, I. D. Davis, J. Cebon, and E. Maraskovsky Role of adenosine receptors in regulating chemotaxis and cytokine production of plasmacytoid dendritic cells Blood, February 15, 2004; 103(4): 1391 - 1397. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Panther, S. Corinti, M. Idzko, Y. Herouy, M. Napp, A. la Sala, G. Girolomoni, and J. Norgauer Adenosine affects expression of membrane molecules, cytokine and chemokine release, and the T-cell stimulatory capacity of human dendritic cells Blood, May 15, 2003; 101(10): 3985 - 3990. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Fossetta, J. Jackson, G. Deno, X. Fan, X. K. Du, L. Bober, A. Soude-Bermejo, O. de Bouteiller, C. Caux, C. Lunn, et al. Pharmacological Analysis of Calcium Responses Mediated by the Human A3 Adenosine Receptor in Monocyte-Derived Dendritic Cells and Recombinant Cells Mol. Pharmacol., February 1, 2003; 63(2): 342 - 350. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Panther, M. Idzko, S. Corinti, D. Ferrari, Y. Herouy, M. Mockenhaupt, S. Dichmann, P. Gebicke-Haerter, F. Di Virgilio, G. Girolomoni, et al. The Influence of Lysophosphatidic Acid on the Functions of Human Dendritic Cells J. Immunol., October 15, 2002; 169(8): 4129 - 4135. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
